Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions.

Schaufele F, Carbonell X, Guerbadot M, Borngraeber S, Chapman MS, Ma AA, Miner JN, Diamond MI.

Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9802-7. Epub 2005 Jul 1.

2.

The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.

Ozers MS, Marks BD, Gowda K, Kupcho KR, Ervin KM, De Rosier T, Qadir N, Eliason HC, Riddle SM, Shekhani MS.

Biochemistry. 2007 Jan 23;46(3):683-95.

PMID:
17223690
3.
5.

The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.

Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B.

Mol Cell Biol. 1999 Sep;19(9):6085-97.

6.

Characterization of nuclear import of the domain-specific androgen receptor in association with the importin alpha/beta and Ran-guanosine 5'-triphosphate systems.

Kaku N, Matsuda K, Tsujimura A, Kawata M.

Endocrinology. 2008 Aug;149(8):3960-9. doi: 10.1210/en.2008-0137. Epub 2008 Apr 17.

7.

Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.

Dubbink HJ, Hersmus R, Verma CS, van der Korput HA, Berrevoets CA, van Tol J, Ziel-van der Made AC, Brinkmann AO, Pike AC, Trapman J.

Mol Endocrinol. 2004 Sep;18(9):2132-50. Epub 2004 Jun 3.

PMID:
15178743
8.

Structural features discriminate androgen receptor N/C terminal and coactivator interactions.

Askew EB, Minges JT, Hnat AT, Wilson EM.

Mol Cell Endocrinol. 2012 Jan 30;348(2):403-10. doi: 10.1016/j.mce.2011.03.026. Epub 2011 Jun 1. Review.

10.

Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.

Jääskeläinen J, Deeb A, Schwabe JW, Mongan NP, Martin H, Hughes IA.

J Mol Endocrinol. 2006 Apr;36(2):361-8.

PMID:
16595706
12.

Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.

Doesburg P, Kuil CW, Berrevoets CA, Steketee K, Faber PW, Mulder E, Brinkmann AO, Trapman J.

Biochemistry. 1997 Feb 4;36(5):1052-64.

PMID:
9033395
13.
14.

Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain.

van de Wijngaart DJ, van Royen ME, Hersmus R, Pike AC, Houtsmuller AB, Jenster G, Trapman J, Dubbink HJ.

J Biol Chem. 2006 Jul 14;281(28):19407-16. Epub 2006 May 11.

15.

Domain interactions between coregulator ARA(70) and the androgen receptor (AR).

Zhou ZX, He B, Hall SH, Wilson EM, French FS.

Mol Endocrinol. 2002 Feb;16(2):287-300.

PMID:
11818501
16.

Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor.

Steketee K, Berrevoets CA, Dubbink HJ, Doesburg P, Hersmus R, Brinkmann AO, Trapman J.

Eur J Biochem. 2002 Dec;269(23):5780-91.

17.

Allosteric conversation in the androgen receptor ligand-binding domain surfaces.

Grosdidier S, Carbó LR, Buzón V, Brooke G, Nguyen P, Baxter JD, Bevan C, Webb P, Estébanez-Perpiñá E, Fernández-Recio J.

Mol Endocrinol. 2012 Jul;26(7):1078-90. doi: 10.1210/me.2011-1281. Epub 2012 May 31.

18.

The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.

Estébanez-Perpiñá E, Moore JM, Mar E, Delgado-Rodrigues E, Nguyen P, Baxter JD, Buehrer BM, Webb P, Fletterick RJ, Guy RK.

J Biol Chem. 2005 Mar 4;280(9):8060-8. Epub 2004 Nov 24.

19.

Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP.

Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S.

Biochemistry. 2001 Dec 18;40(50):15369-77.

PMID:
11735420

Supplemental Content

Support Center